23andMe (ME) - 2024 Q3 - Earnings Call Transcript
23andMe (ME)2024-02-08 02:22
Company Participants Anne Wojcicki - Co-Founder and Chief Executive Officer Jennifer Low - Head of Therapeutics Development Conference Call Participants Operator I would like to turn the call over to Ian Cooney, Senior Director of Investor Relations at 23andMe to lead off the call. Thank you. Please go ahead. Thank you, Valerie. Before we begin, I encourage everyone to go to investors.23andme.com to find the press release we issued earlier today reporting our financial results for the third quarter. A repla ...